Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Narod

Showing results (441-450 of 544) with videos related to

Pageof 55
Sort By:
Journal of the National Cancer Institute|September 8, 2016
Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation CarriersJoanne Kotsopoulos, Tomasz Huzarski, Jacek Gronwald, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|November 29, 2020
Blood cadmium levels as a marker for early lung cancer detectionMarcin R Lener, Edyta Reszka, Wojciech Marciniak, et al.
JAMA Network Open|March 1, 2021
Gene Sequencing for Pathogenic Variants Among Adults With Breast and Ovarian Cancer in the CaribbeanSophia H L George, Talia Donenberg, Cheryl Alexis, et al.
Breast Cancer Research and Treatment|July 11, 2023
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutationJoanne Kotsopoulos, Jacek Gronwald, Tomasz Huzarski, et al.
Cancers|October 17, 2019
Inherited Variants in <i>BLM</i> and the Risk and Clinical Characteristics of Breast CancerWojciech Kluźniak, Dominika Wokołorczyk, Bogna Rusak, et al.
Breast Cancer Research and Treatment|August 30, 2019
Inherited variants in XRCC2 and the risk of breast cancerWojciech Kluźniak, Dominika Wokołorczyk, Bogna Rusak, et al.
Cancers|March 6, 2021
Recurrent Mutations in <i>BRCA1</i>, <i>BRCA2</i>, <i>RAD51C</i>, <i>PALB2</i> and <i>CHEK2</i> in Polish Patients with Ovarian CancerAlicja Łukomska, Janusz Menkiszak, Jacek Gronwald, et al.
Hereditary Cancer in Clinical Practice|March 13, 2010
The 3020insC Allele of NOD2 Predisposes to Cancers of Multiple OrgansJan Lubiński, Tomasz Huzarski, Grzegorz Kurzawski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2005
Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study GroupTimothy R Rebbeck, Tara Friebel, Theresa Wagner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2013
Ten-year survival in patients with BRCA1-negative and BRCA1-positive breast cancerTomasz Huzarski, Tomasz Byrski, Jacek Gronwald, et al.
Pageof 55

Showing results (441-450 of 544) with videos related to

Sort By:
Pageof 55
Journal of the National Cancer Institute|September 8, 2016
Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation CarriersJoanne Kotsopoulos, Tomasz Huzarski, Jacek Gronwald, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|November 29, 2020
Blood cadmium levels as a marker for early lung cancer detectionMarcin R Lener, Edyta Reszka, Wojciech Marciniak, et al.
JAMA Network Open|March 1, 2021
Gene Sequencing for Pathogenic Variants Among Adults With Breast and Ovarian Cancer in the CaribbeanSophia H L George, Talia Donenberg, Cheryl Alexis, et al.
Breast Cancer Research and Treatment|July 11, 2023
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutationJoanne Kotsopoulos, Jacek Gronwald, Tomasz Huzarski, et al.
Cancers|October 17, 2019
Inherited Variants in <i>BLM</i> and the Risk and Clinical Characteristics of Breast CancerWojciech Kluźniak, Dominika Wokołorczyk, Bogna Rusak, et al.
Breast Cancer Research and Treatment|August 30, 2019
Inherited variants in XRCC2 and the risk of breast cancerWojciech Kluźniak, Dominika Wokołorczyk, Bogna Rusak, et al.
Cancers|March 6, 2021
Recurrent Mutations in <i>BRCA1</i>, <i>BRCA2</i>, <i>RAD51C</i>, <i>PALB2</i> and <i>CHEK2</i> in Polish Patients with Ovarian CancerAlicja Łukomska, Janusz Menkiszak, Jacek Gronwald, et al.
Hereditary Cancer in Clinical Practice|March 13, 2010
The 3020insC Allele of NOD2 Predisposes to Cancers of Multiple OrgansJan Lubiński, Tomasz Huzarski, Grzegorz Kurzawski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2005
Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study GroupTimothy R Rebbeck, Tara Friebel, Theresa Wagner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2013
Ten-year survival in patients with BRCA1-negative and BRCA1-positive breast cancerTomasz Huzarski, Tomasz Byrski, Jacek Gronwald, et al.
Pageof 55